Jazz Pharmaceuticals
JAZZ
#2269
Rank
A$10.15 B
Marketcap
$164.49
Share price
0.81%
Change (1 day)
-20.17%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$2.02

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.11. In 2022 the company made an earnings per share (EPS) of -$5.31 an increase over its 2021 EPS that were of -$8.07.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.02-61.92%
2022-$5.31-34.2%
2021-$8.07-224.83%
2020$6.46-53.25%
2019$13.8323.59%
2018$11.19-8.24%
2017$12.1923.74%
2016$9.8522.12%
2015$8.07478.49%
2014$1.39-74.93%
2013$5.56-27.11%
2012$7.6369.1%
2011$4.51245.98%
2010$1.30-462.5%
2009-$0.36-96.7%
2008-$10.92-27.04%
2007-$14.9765.47%
2006-$9.04-4.59%
2005-$9.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.03 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$12.43-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.61-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$3.00 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel